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Evidence of persistent 
executive function deficits in 
cannabis dependence after 
one month of abstinence
Evidências de déficits 
executivos persistentes após 
um mês de abstinência na 
dependência de maconha
Dear Editor, 
Marijuana is the most commonly used illicit drug around the 
world. Information about risks is important for prevention and 
treatment strategies. In this regard, a relevant and well conducted 
review article was published in the Revista Brasileira de Psiquiatria 
by Almeida et al., which has concluded that chronic cannabis 
users (CCU) present executive cognitive functions (ECF) deficits. 
The authors reviewed nine studies of CCU that showed impaired 
abstract reasoning, concept formation, and mental flexibility.1 
ECF may represent a very relevant target for rehabilitation 
strategies, since ECF deficits are associated with poorer outcomes 
in treatment.2 In addition, the literature discussing whether ECF-
related deficits persist after a period of abstinence is contradictory.3 
Pope et al. did not find evidences to support that CCU who 
were 28-day abstinent have persistent ECF-related deficits.4 
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However, Bolla et al. suggested that heavy CCU had persistent 
dose-related cognitive and ECF-related deficits on a range of 
neuropsychological tests, even after 28 days of abstinence.5 The 
aim of this letter is to report a case study that met the diagnostic 
criteria for cannabis dependence and was followed for a period of 
30 days in an inpatient unit. After signing the informed consent, 
the patient was submitted to a very careful neuropsychological 
assessment (NA) focused on ECF, at the treatment entry (1st NA) 
and after 30 days (2nd NA).
Case report: A 36 year-old man was admitted to the impulsive 
behavior ward of the Institute of Psychiatry (IPq), Clinicas 
Hospital, Medical School, Universidade de São Paulo (FMUSP). 
He was 13 years old when he began to smoke cannabis and he 
was 16 when he started to use it almost weekly (every weekend). 
His cannabis use increased progressively and at 20 years old he 
started to smoke daily (one week was the maximum withdrawal 
period) until he was admitted to the ward unit. He has been using 
three joints a day during the last eight months. The NA was based 
mainly on ECF-related tests. The results in the 1st NA showed 
good estimated intellectual efficiency (Intellectual Quotient, IQ: 
105, average), semantic knowledge (vocabulary, from the Wechsler 
Adult Intelligence Scale, Third Edition, WAIS-III) and verbal 
fluency (Controlled Oral Word Association Test, COWAT - see 
Table 1), although the tests demonstrated neuropsychological 
impairments in processing speed/basic attentional processes 
(Trail Making Test, TMT - part A, Stroop Color Word Test, 
SCWT - parts I and II), working memory (Backward Digits, BD), 
planning (The Rey-Osterrieth Complex Figure Test, ROCFT), 
decision making (Iowa Gambling Test, IGT), abstraction 
(Frontal Assessment Battery, FAB, subtest),6 autonomy (FAB 
subtest) and inhibitory control (FAB subtest) corresponding 
to deficits associated with CCU in the literature.4,5 After one 
month of abstinence (2nd NA), which was verified by self-report 
and supervised by the clinical staff, there was an improvement 
in decision-making, planning, verbal fluency, abstraction and 
autonomy, as well as a slight improvement in working memory 
and mental flexibility (perseverative errors – Wisconsin Card 
Sorting Test, WCST). In spite of this, his performance on ECF 
tasks such as TMT - Part B and BD remained somewhat below the 
normal range (Low Average). Additionally, the patient remained 
with an important deficit in the FAB’s inhibitory control subtest 
(Figure 1) and he had a poorer performance in attention span 
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(Forward Digits, FD) and failures to maintain set in WCST. In 
his daily life he had problems associated with finances, job, and 
family (the patient was unable to financially support himself and 
to have a satisfactory relationship with his parents, especially with 
his mother).
It is relevant to highlight that in the 1st and 2nd NA, the patient 
has showed apparently unexpected superior results in WCST 
(especially in completed categories). Yet, WCST impairment 
findings in CCU are rather inconsistent.4,5 Also, his abstraction 
performance in WCST corresponds to his good estimated 
premorbid intellectual efficiency (showed by Vocabulary – WAIS-
III). On the other side, his poor performance on the TMT and on 
the SCWT (part I and II) could have occurred due to processing 
speed deficits. It is possible that the patient revealed different 
performances on diverse tests (WCST, TMT and SCWT), because 
they measure distinct functions.
Despite some improvement in ECF, the patient did not reach 
a normal functioning in the 2nd NA. Also, the FAB detected 
inhibitory control impairments that persisted throughout the 
period of one month of abstinence. Considering that there were 
no differences regarding the severity of depressive and anxious 
symptoms between the 1st and 2nd NA, the persistent ECF-related 
deficits were unlikely to be associated with withdrawal effects.
In conclusion, even after 30 days of withdrawal, ECF-
related deficits were observed in cannabis dependence that 
may be associated with problems in the patient’s daily life. The 
improvement seen in certain cognitive functions should be 
carefully interpreted. First, where there were indeed improvements, 
they were modest, and impaired performance appeared to persist 
across many measures. Second, certain neuropsychological tasks 
such as ROCFT are subject to practice effects due to repetitive 
testing. Longitudinal studies are needed for further investigation 
on the persistence of ECF changes and the impact on the daily 
activities of cannabis users.
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Depressão durante a gravidez 
no sistema público de saúde 
brasileiro
Depression during pregnancy 
in the Brazilian public health 
care system
Caros Editores,
Gostaríamos de parabenizar os autores Silva et al. pelo trabalho 
recém-publicado na Revista Brasileira de Psiquiatria1. O artigo 
avalia a prevalência e fatores associados à depressão em gestantes 
atendidas por meio do sistema público de saúde da cidade de 
Pelotas. Trata-se de pesquisa de enorme relevância para a saúde 
pública que aborda tema frequentemente relegado a plano 
secundário na assistência às gestantes. O estudo mostra que 21% 
das participantes apresentam episódio depressivo na gravidez, 
ressaltando a importância do papel do profissional de saúde 
no diagnóstico precoce e adoção de medidas terapêuticas. No 
entanto, gostaríamos de fazer um reparo ao trabalho e comentar 
seus resultados. 
Na introdução, os autores afirmam que este é primeiro estudo 
nacional em amostra representativa da população. Nosso artigo 
“Common mental disorders during pregnancy: prevalence and 
associated factors among low-income women in São Paulo, Brazil”, 
publicado no periódico Archives of Womens’ Mental Health, em 
20092, avaliou um grupo de 831 gestantes com características 
sociodemográficas muito semelhantes atendidas em pré-natal 
nas unidades de atenção primária do sistema público de saúde da 
região Oeste da cidade de São Paulo. Gostaríamos de destacar que 
a prevalência de depressão/ansiedade avaliada por meio da Clinical 
Interview Schedule-Revised (CIS-R) foi igualmente de 20%. 
Quanto aos fatores associados à depressão, também observamos 
que história de tratamento psiquiátrico prévio, uso de álcool e 
tabagismo mostraram-se fortemente associados com prevalência 
de depressão. Também do mesmo modo que o observado por Silva 
et al.1, não ter parceiro (p = 0,09) e baixa escolaridade (0,02) se 
associaram com depressão apenas na análise univariada. Por outro 
lado, diferentemente dos resultados do estudo de Pelotas, não 
encontramos associação entre depressão na gestação e número de 
gestações anteriores, gravidez planejada ou ter mais idade. Pelo 
contrário, em nossa amostra, a idade mais jovem na gestação atual 
é que apresentou associação estatisticamente significante com o 
desfecho em questão, sugerindo que talvez fatores contextuais 
possam modificar a associação entre idade e depressão na gravidez. 
Por se tratar de problema tão prevalente e com potenciais 
consequências para a mulher e para o bebê, a exemplo de nossos 
colegas de Pelotas, acreditamos que novas pesquisas nacionais 
sobre depressão no ciclo gravídico-puerperal são necessárias para 
auxiliar no desenvolvimento de programas e políticas públicas 
que permitam melhorar efetivamente a assistência às gestantes 
oferecida pelo Sistema Único de Saúde do país.
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